- cafead Sep 13, 2023 at 11:22: AM
via Altimmune has completed dosing the last subject in its Phase II MOMENTUM clinical trial of pemvidutide to treat obesity or overweight.
The placebo-controlled, randomised, multi-centre study is being carried out at nearly 30 sites in the US.
article source
The placebo-controlled, randomised, multi-centre study is being carried out at nearly 30 sites in the US.
article source